PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Semaglutide - Weight management in adults

PAD Profile : Semaglutide - Weight management in adults

Keywords :
obesity, weight loss, weight management, overweight
Brand Names Include :
Wegovy

Traffic Light Status

Status 1 of 1.

Status :
N/A
Formulations :
  • Subcutaneous injection (sc)
Trust Alignment :
Primary Care
ASPH
RSCH
SASH
SABP
Links :
Comments :
No comments returned.

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
06 December 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

December 2023 - Update on availability of Wegovy® (semaglutide) to support weight loss

In Surrey Heartlands, we have begun discussions locally about the use of Wegovy® and this has included a discussion at our Area Prescribing Committee. Due to a number of complexities, and some wider implications we would need to consider, implementation will be discussed at a meeting of NHS Surrey Heartland’s Commissioning, Contracting and Commercial Committee in January 2024. We will provide a further update following this meeting.
 

Please see further information in the update on availability of Wegovy.

Associated BNF Codes

06. Endocrine System
06.01.02. Antidiabetic drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More